Table I -.

Patient features and treatment method

Patient parameter	n (%)
Age (years)	Median 49
	Range 43-55
Gender	Female
Clinical stage
Stage II	26 (46.4%)
Stage IV	30 (53.5%)
Chemotherapy regime
AC × 4	29 (51.7%)
AC × 4 followed by T × 4	27 (48.2%)
Histological type	IDC
HER2 receptor	Negative

A = adriamycin; C = cyclophosphamide; HER = human epidermal growth factor receptor; T = taxane; IDC = Invasive ductal carcinoma.